Jazz Pharmaceuticals plc — Director's Dealing 2016

Aug 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-08-07

Reporting Person: Cox Russell J. (EVP & COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-07	Ordinary Shares	F	978.0	$149.02	Disposed	59603	Direct
2016-08-09	Ordinary Shares	F	4565.0	$150.01	Disposed	55038	Direct
2016-08-09	Ordinary Shares	S	4000.0	$148.66	Disposed	51038	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 111 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2016.

F3: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.